Report

Update: Capital raising gives time to grow sales

Simavita’s Smart Incontinence Management (SIM) platform improves the management of urinary incontinence in residential care settings. Our forecasts indicate that the A$8m (net) capital raise in April 2015 may make the company fully funded to profitability, which we forecast to be achieved in FY17. Our DCF valuation is A$107m (vs A$100m) or A$1.16/share.
Underlying
Simavita - CDI

Provider
Edison Investment Research
Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

.

Other Reports on these Companies
Other Reports from Edison Investment Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch